- Home
- TVTX vs FBNC Comparison
TVTX vs FBNC Comparison
Compare TVTX & FBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TVTX | FBNC |
|---|---|---|
| Founded | N/A | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 2.7B |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TVTX | FBNC |
|---|---|---|
| Price | $66.45 | $64.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | $40.62 | ★ $62.25 |
| AVG Volume (30 Days) | ★ 1.2M | 146.0K |
| Earning Date | 05-04-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.67% |
| EPS Growth | ★ 92.89 | 45.65 |
| EPS | N/A | ★ 2.35 |
| Revenue | N/A | ★ $67,623,000.00 |
| Revenue This Year | $44.76 | $37.82 |
| Revenue Next Year | $35.51 | $2.30 |
| P/E Ratio | ★ N/A | $27.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.06 | $45.96 |
| 52 Week High | $68.23 | $66.78 |
Technical Indicators
Market Signals| Indicator | TVTX | FBNC |
|---|---|---|
| Relative Strength Index (RSI) | 62.07 | 49.89 |
| Support Level | $53.76 | $62.03 |
| Resistance Level | N/A | $66.33 |
| Average True Range (ATR) | 2.21 | 1.13 |
| MACD | -0.27 | -0.03 |
| Stochastic Oscillator | 71.14 | 66.02 |
Price Performance
Historical ComparisonAbout TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing, and investment advisory services.